Urocortin expression in synovium of patients with rheumatoid arthritis andosteoarthritis: Relation to inflammatory activity

Citation
M. Kohno et al., Urocortin expression in synovium of patients with rheumatoid arthritis andosteoarthritis: Relation to inflammatory activity, J CLIN END, 86(9), 2001, pp. 4344-4352
Citations number
58
Categorie Soggetti
Endocrynology, Metabolism & Nutrition","Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF CLINICAL ENDOCRINOLOGY AND METABOLISM
ISSN journal
0021972X → ACNP
Volume
86
Issue
9
Year of publication
2001
Pages
4344 - 4352
Database
ISI
SICI code
0021-972X(200109)86:9<4344:UEISOP>2.0.ZU;2-X
Abstract
Peripherally produced CRH acts as a local auto/paracrine proinflammatory ag ent. Urocortin is a new member of the CRH family that acts through the fami ly of CRH receptors. In this study, we demonstrated that the expression of urocortin mRNA in synovia of patients with rheumatoid arthritis was greater than that of patients with osteoarthritis. Also, we detected urocortin and CRH receptor immunoreactivity in the synovial lining cell layer, subsynovi al stromal cells, blood vessel endothelial cells, and mononuclear inflammat ory cells from the joints of rheumatoid arthritis and osteoarthritis patien ts. The expression of immunoreactive urocortin was significantly greater in rheumatoid arthritis than ostcoarthritis (P<0.0001) and correlated with th e extent of inflammatory infiltrate. CRH receptor immunoreactivity was stro ng in mononuclear inflammatory cells of rheumatoid arthritis synovia. Uroco rtin stimulated <beta>IL-1 and IL-6 secretion by human peripheral blood mon onuclear cells in vitro. These findings suggest that, like CRH, urocortin i s present in peripheral inflammatory sites, such as rheumatoid synovium, an d acts as an immune-inflammatory mediator.